What are the latest guidelines for the treatment of multiple myeloma?

Reviewed by Yoshinori Abe, MD

Internal Medicine

Multiple myeloma treatment guidelines now prioritize personalized care, tailoring therapy to each patient's eligibility for stem cell transplant. Updated protocols introduce novel drug combinations—including monoclonal antibodies, immunomodulators, and proteasome inhibitors—for both transplant-eligible and non-eligible patients, improving outcomes and long-term disease control.

If you're experiencing symptoms like persistent bone pain, fatigue, frequent infections, or unexplained weight loss, early evaluation matters. A free, instant, online symptom check can help you understand what your symptoms may mean and guide your next steps—empowering you to have a more informed conversation with your doctor.

Reviewed for medical accuracy: 07/14/2026

Important Next Steps

Learn if symptoms could suggest multiple myeloma Discover whether your symptoms need urgent care See if multiple myeloma fits your symptoms Find OTC options for symptom relief Find a doctor for multiple myeloma care Understand medically valid home remedies for symptoms Discover likely causes of possible multiple myeloma

Not seeing your question? No worries.

Submit your own Question

Explanation

The treatment of multiple myeloma has advanced with new guidelines focusing on personalized care. For patients eligible for a stem cell transplant, the recommended approach involves initial treatment with medications that help reduce cancer cells, followed by the transplant to replace damaged bone marrow. Non-transplant patients often receive a combination of medications tailored to their specific needs. If you're experiencing unusual symptoms and want to better understand what might be causing them, try Ubie's free AI symptom checker to help guide your next steps.

Key Points:

Transplant-Eligible Patients: Initial therapy usually includes drugs that target the myeloma cells, followed by a stem cell transplant.
Non-Transplant Patients: Treatment often involves a combination of medications, including newer drugs that have shown to be effective.
Personalized Medicine: Treatment plans are tailored to the individual, taking into account the patient's overall health, age, and specific characteristics of their myeloma.

These guidelines highlight the importance of using the latest available therapies and considering each patient's unique situation to provide the most effective treatment.

(References)

Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, et al. (2025). NCCN Guidelines® Insights: Multiple Myeloma, Version .... Journal of the National Comprehensive Cancer Network : JNCCN, 40340857.
Khan S, Bergstrom DJ, Côté J, Kotb R, LeBlanc R, Louzada ML, et al. (2025). First Line Treatment of Newly Diagnosed Transplant .... Clinical lymphoma, myeloma & leukemia, 39567294.
Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, et al. (2021). Multiple myeloma: EHA-ESMO Clinical Practice Guidelines .... Annals of oncology : official journal of the European Society for Medical Oncology, 33549387.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.